4.8 Article Proceedings Paper

Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Results of DAPA-HF

Pardeep S. Jhund et al.

Summary: The study found that dapagliflozin had consistent safety and efficacy in patients with heart failure and reduced ejection fraction regardless of kidney function status, and it could slow down the decline in eGFR. This effect was observed in patients with and without diabetes.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure Results From the EMBRACE-HF Trial

Michael E. Nassif et al.

Summary: The EMBRACE-HF trial showed that empagliflozin significantly reduced pulmonary artery diastolic pressure in patients with heart failure, with effects increasing over time and appearing to be independent of loop diuretic management.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial

Stuart J. Pocock et al.

Summary: This study aimed to develop a prognostic tool for patients with chronic HFrEF by using biomarkers NT-proBNP and hs-cTnT with a small number of clinical variables. The risk model showed good discrimination and was validated in the BIOSTAT-CHF study, indicating that it can be easily implemented for routine clinical use.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Theresa A. McDonagh et al.

EUROPEAN HEART JOURNAL (2021)

Article Cardiac & Cardiovascular Systems

Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial

Milton Packer et al.

Summary: Elevations in circulating troponin levels reflect the clinical severity, stability, and prognosis of patients with heart failure and a reduced ejection fraction, with biomarkers, comorbidities, clinical course, and risks proportional to the magnitude of troponin elevation. Empagliflozin demonstrated favorable effects on heart failure and renal outcomes, regardless of the baseline concentration of troponin.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Article Cardiac & Cardiovascular Systems

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Matthew M. Y. Lee et al.

Summary: The study confirmed the effectiveness of sodium-glucose cotransporter 2 inhibitor empagliflozin in reducing left ventricular volumes in patients with HFrEF, favoring reverse left ventricular remodeling. This may be one of the mechanisms by which sodium-glucose cotransporter 2 inhibitors reduce heart failure hospitalization and mortality in HFrEF.

CIRCULATION (2021)

Article Cardiac & Cardiovascular Systems

Effects of dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring

Wilfried Mullens et al.

ESC HEART FAILURE (2020)

Article Cardiac & Cardiovascular Systems

N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes

Justin A. Ezekowitz et al.

JACC-HEART FAILURE (2020)

Article Medicine, General & Internal

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

J. J. V. McMurray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Cardiac & Cardiovascular Systems

Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes

James L. Januzzi et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure Analysis From the PROTECT Pilot Study

Christopher M. O'Connor et al.

CIRCULATION-HEART FAILURE (2011)

Review Cardiac & Cardiovascular Systems

Troponin Elevation in Heart Failure Prevalence, Mechanisms, and Clinical Implications

Robb D. Kociol et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Profiles of Serial Changes in Cardiac Troponin T Concentrations and Outcome in Ambulatory Patients With Chronic Heart Failure

Wayne L. Miller et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)